KLTO (Klotho Neurosciences) Short-Term Debt : $0.15 Mil (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Klotho Neurosciences Short-Term Debt?

Klotho Neurosciences's Short-Term Debt for the quarter that ended in Sep. 2024 was $0.15 Mil.

Klotho Neurosciences's quarterly Short-Term Debt declined from Mar. 2024 ($1.52 Mil) to Jun. 2024 ($0.03 Mil) but then increased from Jun. 2024 ($0.03 Mil) to Sep. 2024 ($0.15 Mil).

Klotho Neurosciences's annual Short-Term Debt stayed the same from . 20 ($0.00 Mil) to Dec. 2021 ($0.00 Mil) but then increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($1.35 Mil).

Klotho Neurosciences Short-Term Debt Historical Data

The historical data trend for Klotho Neurosciences's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Klotho Neurosciences Short-Term Debt Chart

Klotho Neurosciences Annual Data

Trend

Dec21

Dec22

Short-Term Debt

1.35

Klotho Neurosciences Quarterly Data
	Dec21	Jun22	Dec22	Jun23	Sep23	Mar24	Jun24	Sep24
Short-Term Debt	Get a 7-Day Free Trial			1.35	-	1.52	0.03	0.15

Klotho Neurosciences Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Klotho Neurosciences Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Klotho Neurosciences's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Klotho Neurosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Klotho Neurosciences Inc (NAS:KLTO) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

13576 Walnut Street, 12th Floor, Omaha, NE, USA, 68144

Website

https://www.klothoneuro.com

Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.